Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Placenta size may warn of pregnancy dangers, study finds

NCT ID NCT07337759

Knowledge-focused Sponsor: University of Belgrade Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether the weight and surface area of the placenta can help predict serious pregnancy complications, such as early delivery, low birth weight, or poor newborn health. Researchers examined placentas from 440 women, including those with conditions like high blood pressure or diabetes. They found that smaller-than-expected placentas were linked to worse outcomes for both mother and baby.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

440 people

The number who actually took part.

Started

Dec 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Pregnant women with singleton pregnancies who delivered at the Clinic of Gynecology and Obstetrics, University Clinical Centre of Serbia. The study population includes both healthy pregnant women and women with maternal comorbidities such as hypertensive disorders, diabetes mellitus, and thrombophilia. Placentas were examined after delivery and classified according to placental weight for gestational age.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Pregnant women who delivered at the Clinic of Gynecology and Obstetrics, University Clinical Centre of Serbia * Singleton pregnancy * Available placental examination after delivery * Available clinical and perinatal outcome data * Gestational age at delivery ≥24 weeks Exclusion Criteria: Multiple pregnancy (e.g., twins or higher-order gestations) * Major congenital or chromosomal fetal anomalies * Intrauterine fetal demise * Conditions directly affecting placental weight (e.g., placental mosaicism) * Incomplete clinical, placental, or histopathological data

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Placental insufficiency hypertensive disorders of pregnancy diabetes mellitus in pregnancy thrombophilia in pregnancy adverse perinatal outcomes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Placental insufficiency hypertensive disorders of pregnancy diabetes mellitus in pregnancy thrombophilia in pregnancy adverse perinatal outcomes

Contacts and locations

Locations

  • Clinic of Gynecology and Obstetrics, University Clinical Center of Serbia

    Belgrade, Serbia